top of page
The Professional Network for Healthcare Experts
Karyopharm plans Ayrmid merger through Chapter 11 restructuring with $55 million financing commitment
Karyopharm Therapeutics has announced a proposed merger with Ayrmid through a court-supervised Chapter 11 restructuring process, supported by a $55 million additional financing commitment.
nuaxia
2 days ago2 min read
Ipsen bets up to $1.75bn on Kartos to strengthen myelofibrosis pipeline
Late-stage myelofibrosis candidate navtemadlin could reshape treatment for patients with suboptimal responses to Jakafi.
nuaxia
Jul 13 min read
bottom of page